PULSESIGHT THERAPEUTICS

Serial Number 98240367
731

Registration Progress

Application Filed
Oct 25, 2023
Under Examination
Oct 1, 2024
Approved for Publication
Aug 6, 2024
Published for Opposition
Aug 6, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Apr 01, 2026 143 days

Trademark Image

PULSESIGHT THERAPEUTICS

Basic Information

Serial Number
98240367
Filing Date
October 25, 2023
Published for Opposition
August 6, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Aug 27, 2025
Application
Pending
Classes
042

Rights Holder

PULSESIGHT THERAPEUTICS

03
Address
BIOPARK BÂTIMENT B - 11 RUE WATT
PARIS 75013
FR

Ownership History

EYEVENSYS, INC.

Original Applicant
03
Paris FR

PULSESIGHT THERAPEUTICS

New Owner Before Publication #1
03
PARIS FR

PULSESIGHT THERAPEUTICS

Owner at Publication
03
PARIS FR

Legal Representation

Attorney
Ronald M. Kachmarik

USPTO Deadlines

Next Deadline
143 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
April 01, 2026
Extension Available
Until October 01, 2025

Application History

26 events
Date Code Type Description Documents
Aug 28, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 27, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 27, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 27, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 10, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 7, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 7, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 7, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 4, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 4, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 4, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 4, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 4, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 1, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 6, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 6, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 4, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 27, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 27, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 27, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 27, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 27, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 8, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 31, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 28, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical research; Medical and scientific research in the field of retinal medicine and treatments; Medical and scientific research in the field of eye health; Medical research in the field of ophthalmology; Scientific research for medical purposes in the area of ophthalmology; Scientific research for medical purposes in the area of retinal and ophthalmologic diseases and conditions; Scientific research for medical purposes in the area of retinal and ophthalmologic treatments and pharmaceuticals; Pharmaceutical research and development; Pharmaceutical research and development for retinal and ophthalmologic diseases and conditions; Pharmaceutical research and development for improving eye health

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"